| Primary information |
|---|
| ID | 13174 |
| Uniprot ID | P30990 |
| Description | Neurotensin/neuromedin N [Cleaved into- Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide] |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted Cytoplasmic vesicle; secretory vesicle. Note=Packaged within secretory vesicles. |
| Developmental Stage | NA |
| Similarity | Belongs to the neurotensin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Neurotensin may play an endocrine or paracrine role in the regulation of fat metabolism. It causes contraction of smooth muscle. |
| Length | 170 |
| Molecular Weight | 19 |
| Name | Neurotensin/neuromedin N |
| Sequence | QLYENKPRRPYIL |
| Sequence map | 312 |
| PDB ID | 9530155; 15489334; 1436492; 11294867; 19122660; 23140271 |
| Drugpedia | 2LNE;2LNF;2LNG;2LYW;2OYV;2OYW;3F6K;4PO7;5LUZ;6UP7; |
| Receptor | P30989; P08138; P30989; O95665; Q99523 |
| Domain | NA |
| Pharmaceutical Use | NA
|